[1]晏 莉,杨 芳,王 俊,等.真武汤加减对液体复苏后“痰饮症”患者中心静脉压、氧合指数以及下腔静脉呼吸变异指数的影响[J].陕西中医,2024,(9):1207-1210.[doi:DOI:10.3969/j.issn.1000-7369.2024.09.012]
　YAN Li,YANG Fang,WANG Jun,et al.Effect of Zhenwu decoction on central venous pressure,oxygenation index and inferior vena cava respiratory variation index in patients with phlegm syndrome after fluid resuscitation[J].,2024,(9):1207-1210.[doi:DOI:10.3969/j.issn.1000-7369.2024.09.012]
点击复制

真武汤加减对液体复苏后“痰饮症”患者中心静脉压、氧合指数以及下腔静脉呼吸变异指数的影响
分享到：

《陕西中医》[ISSN:1000-7369/CN:61-1281/TN]

卷:
期数:
2024年9期
页码:
1207-1210
栏目:
临床研究
出版日期:
2024-09-05

文章信息/Info

Title:
Effect of Zhenwu decoction on central venous pressure,oxygenation index and inferior vena cava respiratory variation index in patients with phlegm syndrome after fluid resuscitation
作者:
晏 莉; 杨 芳; 王 俊; 薛 敏
(四川省第二中医医院重症医学科,四川 成都 610031)
Author(s):
YAN Li; YANG Fang; WANG Jun; XUE min
(Department of Critical Care Medicine,Second Traditional Chinese Medicine Hospital of Sichuan Province,Chengdu 610031,China)
关键词:
痰饮症;  液体复苏;  真武汤;  中心静脉压;  氧合指数;  下腔静脉呼吸变异指数
Keywords:
Fluid resuscitation;  Phlegm retention syndrome;  Zhenwu decoction;  Central venous pressure;  Oxygenation index;  Inferior vena cava respiratory variability index
分类号:
R 255.8
DOI:
DOI:10.3969/j.issn.1000-7369.2024.09.012
文献标志码:
A
摘要:
目的:探讨加减真武汤对液体复苏后“痰饮症”患者中心静脉压、氧合指数以及下腔静脉呼吸变异指数的影响。方法:将104例完成液体复苏后的液体过负荷的感染性休克患者随机分为两组,对照组52例,给予常规西医脱水治疗; 研究组52例,在对照组基础上给予真武汤加减治疗。比较两组患者治疗前后的临床疗效、中医证候积分、中心静脉压(CVP)、氧合指数(OI)以及下腔静脉呼吸变异指数(RVI)的变化。结果:研究组总有效率92.31%高于对照组73.07%(P<0.05); 治疗后中医症候积分较治疗前均有所下降,且研究组低于对照组,差异有统计学意义(均P<0.05); 脱水治疗后,研究组和对照组CVP在1、7、14 d逐渐降低,差异有统计学意义(均P<0.05); 两组患者在不同时间段OI不断升高,且研究组高于对照组,差异有统计学意义(均P<0.05); RVI在不同时间段逐渐降低,且研究组低于对照组,差异有统计学意义(均P<0.05)。结论:真武汤加减能有效改善液体复苏后“痰饮症”患者的临床症状,降低中心静脉压,提高氧合指数,降低呼吸变异指数。
Abstract:
Objective:To investigate the effect of modified Zhenwu decoction on central venous pressure,oxygenation index and respiratory variation index of inferior vena cava in patients with phlegm retention syndrome after fluid resuscitation.Methods:104 patients with septic shock after fluid resuscitation were randomly divided into two groups:a control group of 52 cases,receiving conventional Western medicine dehydration treatment,and a study group of 52 cases,receiving modified Zhenwu Tang treatment on the basis of the control group.Clinical efficacy,TCM syndrome integral,central venous pressure(CVP),oxygenation index(OI)and respiratory variability index(RVI)of inferior vena cava were compared between the two groups before and after treatment.Results:The total effective rate in the study group(92.31%)was higher than that in the control group(73.07%)(P<0.05).After the treatment,the scores of TCM symptoms in the study group were lower than those in the control group,and the differences were statistically significant(P<0.05),After dehydration treatment,the CVP of the study group and the control group gradually decreased on day 1,7,and 14,with statistically significant differences(all P<0.05); The OI levels of the two groups of patients continued to increase at different time periods,and the study group was higher than the control group,with statistically significant differences(all P<0.05).RVI decreased gradually at different time points after fluid resuscitation,and the study group was lower than that of the control group,with statistical significance(P<0.05).Conclusion:Zhenwu decoction can effectively improve the clinical symptoms of patients with phlegm retention syndrome after fluid resuscitation,reduce central venous pressure,improve oxygenation index and reduce respiratory variability index.

参考文献/References:

[1] 戴春.负平衡液体管理对感染性休克伴急性肺损伤患者心肺功能指标转归影响分析[J].陕西医学杂志,2018,47(4):442-444.
[2] GORDON D,SPIEGEL R.Fluid resuscitation:History,physiology,and modern fluid resuscitation strategies[J].Emerg Med Clin North Am,2020,38(4):783-793.
[3] 林柏柏,沈梦雯,钱义明,等.从“痰饮”论治脓毒症毛细血管渗漏综合征[J].陕西中医,2021,42(2):222-224,238.
[4] 张建伟,王苹.“痰”、“饮”析辨[J].成都中医药大学学报,2012,35(2):16-17,20.
[5] 彭艳,肖飞.真武汤加减联合盐酸纳美芬对老年脓毒性休克患者血流动力学及免疫功能的影响[J].陕西中医,2022,43(7):897-901.
[6] LIU Z,SHANG Q,LI H,et al.Exploring the possible mechanism(s)underlying the nephroprotective effect of Zhenwu decoction in diabetic kidney disease:An integrated analysis[J].Phytomedicine,2023,119:154988.
[7] LIU B,LU R,LI H,et al.Zhen-wu-tang ameliorates membranous nephropathy rats through inhibiting NF-κB pathway and NLRP3 inflammasome[J].Phytomedicine,2019,59:152913.
[8] 戴春.负平衡液体管理对感染性休克伴急性肺损伤患者心肺功能指标转归影响分析[J].陕西医学杂志,2018,47(4):442-444.
[9] 张伯礼,吴勉华.中医内科学(新世纪第四版)[M].北京:中国中医药出版社,2017,460-461.
[10] 国家食品药品监督管理局.中药新药临床研究指导原则[M].北京:中国医药科技出版社,2002:53-60.
[11] 孙璇.痰饮新解:饮邪为阴邪,非温不化; 痰为本寒标热,清热不远温[J].环球中医药,2024,10(3):473-476.
[12] 招金娣,丁珊珊,廖凌虹.《金匮要略》水饮论治浅析[J].河南中医,2023,43(8):1139-1141.
[13] 万小曼,吴松.基于“以温药和之”理论探讨痰饮病治疗[J].湖北中医药大学学报,2023,25(5):51-54.
[14] 陈英.基于《伤寒杂病论》治痰理论探讨痰饮眩晕辨证论治[J].四川中医,2018,36(11):28-30.
[15] 赵中振.李时珍与《本草纲目》[J].中国食品药品监管,2023,12(8):128-133,158.
[16] CARDOZO L C M,LEMOS G S D.Fluid responsiveness assessment using inferior vena cava collapsibility among spontaneously breathing patients:Systematic review and meta-analysis[J].Med Intensiva(Engl Ed),2023,47(2):90-98.
[17] 侯燕燕,陈新卫,田颖,等.连续性肾脏替代治疗联合限制性液体复苏在重症急性胰腺炎治疗中的应用价值[J].陕西医学杂志,2023,52(12):1711-1714.
[18] LU N,XI X,JIANG L,et al.Exploring the best predictors of fluid responsiveness in patients with septic shock[J].Am J Emerg Med,2017,35(9):1258-1261.
[19] HAMZAOUI O,TEBOUL J L.Central venous pressure(CVP)in intensive care med[J].Intensive Care Med,2022,48(10):1498-1500.
[20] 陈义富,张忠德,黎伟强.机械通气脓毒症休克患者下腔静脉管径/呼吸变异指数与中心静脉压的关系[J].甘肃医药,2020,39(3):210-211.
[21] COURNOYER A,CAVAYAS Y A.Central venous pressure amplitude:A novel marker of resuscitation quality[J].Resuscitation,2023,185:109749.
[22] 丁秀丽,袁恒佑.加味真武汤联合稳心颗粒治疗缓慢型心律失常心肾阳虚证临床研究[J].陕西中医,2024,45(4):498-501.
[23] LIU B,LU R,LI H,et al.Zhen-wu-tang ameliorates membranous nephropathy rats through inhibiting NF-κB pathway and NLRP3 inflammasome[J].Phytomedicine,2019,59:152913.
[24] 刘翠华,向海.氧合指数及弥散指数与重度急性呼吸窘迫综合征患者呼气末正压治疗后肺可复张性和预后的关系研究[J].临床急诊杂志,2022,23(6):395-399.
[25] LIU B,CAO Y,WANG D,et al.ZhenwuTang induced mitophagy to protect mitochondrial function in chronic glomerulonephritis via PI3K/AKT/mTOR and AMPK pathways[J].Front Pharmacol,2021,12:777670.

相似文献/References:

[1]薛 敏,晏 莉,杨 芳,等.温阳利水法治疗感染性休克液体复苏后患者体液潴留临床研究[J].陕西中医,2024,(8):1070.[doi:DOI:10.3969/j.issn.1000-7369.2024.08.013]
　XUE Min,YAN Li,YANG Fang,et al.Clinical study on the treatment of fluid retention after fluid resuscitation for septic shock based on warming yang to promote diuresis method[J].,2024,(9):1070.[doi:DOI:10.3969/j.issn.1000-7369.2024.08.013]

备注/Memo

备注/Memo:
基金项目:四川省中医药管理局科学技术研究专项课题(2021MS309)
更新日期/Last Update: 2024-09-09